Mutational Analysis of a Transforming Growth Factor-β Receptor Binding Site

References

• Archer S. J., Bax A., Roberts A. B., Sporn M. B., Ogawa Y., Piez K. A., Weatherbee J. A., Tsang M. L., Lucas R., Zheng B. L., Wenker J., Torchia D. A. Transforming growth factor β1: NMR signal assignments of the recombinant protein expressed and isotopically enriched using Chinese hamster ovary cells. Biochemistry 1993a; 32(4)1152–1163
   PubMed Web of Science ®Google Scholar
• Archer S. J., Bax A., Roberts A. B., Sporn M. B., Ogawa Y., Piez K. A., Weatherbee J. A., Tsang M. L., Lucas R., Zheng B. L., Wenker J., Torchia D. A. Transforming growth factor β1: Secondary structure as determined by heteronuclear magnetic resonance spectroscopy. Biochemistry 1993b; 32(4)1164–1171
   PubMed Web of Science ®Google Scholar
• Beck L. S., Chen T. L., Hirabayashi S. E., Deguzman L., Lee W. P., McFatridge L. L., Xu Y., Bates R. L., Ammann A. J. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-β1. Growth Factors 1990; 2(4)273–282
   PubMed Web of Science ®Google Scholar
• Brunner A. M., Marquard H., Malacko A. R., Lioubin M. N., Purchio A. F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 1989; 264(23)13660–13664
   PubMed Web of Science ®Google Scholar
• Burmester J. K., Qian S. W., Roberts A. B., Huang A., Ama-tayakul-Chantler S., Suardet L., Odartchenko N., Madri J. A., Sporn M. B. Characterization of distinct functional domains of transforming growth factor-β. Proc. Natl. Acad. Sci. USA 1993; 90(18)8628–8632
   PubMed Web of Science ®Google Scholar
• Castilla A., Prieto J., Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med. 1991; 324(14)933–940
   PubMed Web of Science ®Google Scholar
• Cheifetz S., Hernandez H., Laiho M., ten Dijke P., Iwata K. K., Massagué J. Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J. Biol. Chem. 1990; 265(33)20533–20538
   PubMed Web of Science ®Google Scholar
• Cheifetz S., Bellón T., Calés C., Vera S., Bernabeus C., Massagué J., Letarte M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem. 1992; 267(27)19027–19030
   PubMed Web of Science ®Google Scholar
• Chen R. H., Ebner R., Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993; 260(5112)1335–1338
   PubMed Web of Science ®Google Scholar
• Danielpour D., Dart L. L., Flanders K. C., Roberts A. B., Sporn M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 1989; 138(1)79–86
   PubMed Web of Science ®Google Scholar
• Daopin S., Piez K. A., Ogawa Y., Davies D. R. Crystal structure, of transforming growth factor-β2: An unusual fold for the superfamily. Science 1992; 257(5068)369–373
   PubMed Web of Science ®Google Scholar
• Frolik C. A., Wakefield L. M., Smith D. M., Sporn M. B. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem. 1984; 259(17)10995–11000
   PubMed Web of Science ®Google Scholar
• Geiser A. G., Burmester J. K., Webbink R., Roberts A. B., Sporn M. B. Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem. 1992; 267(4)2588–2593
   PubMed Web of Science ®Google Scholar
• Hahn S. A., Hoque A. T. M. S., Moskaluk C. A., da Costa L. T., Schutte M., Rozenblum E., Seymour A. B., Wein-Stein C. L., Yeo C. J., Hruban R. H., Kern S. E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 1996; 56(3)490–494
   PubMed Web of Science ®Google Scholar
• Hanks S. K., Armour R., Baldwin J. H., Maldonado F., Spiess J., Holley R. W. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc. Natl. Acad. Sci. USA 1988; 85(1)79–82
   PubMed Web of Science ®Google Scholar
• Higuchi R., Krummel B., Saiki R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988; 16(15)7351–7367
   PubMed Web of Science ®Google Scholar
• Hinck A. P., Archer S. J., Qian S. W., Roberts A. B., Sporn M. B., Weatherbee J. A., Tsang M. L.-S., Lucas R., Zheng B.-L., Wenker J., Torchia D. A. Transforming growth factor β1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry 1996; 35(26)8517–8534
   PubMed Web of Science ®Google Scholar
• Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Noble N. A., Border W. A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 1996; 2(4)418–423
   PubMed Web of Science ®Google Scholar
• Khalil N., Greenberg A. H. The role of TGF-β in pulmonary fibrosis. Ciha Found. Symp. 1991; 157: 194–207
   PubMedGoogle Scholar
• Koli K. M., Arteaga C. L. Predominant cytosolic localization of type II transforming growth factor-β receptors in human breast carcinoma cells. Cancer Res. 1997; 57: 970–977
   PubMed Web of Science ®Google Scholar
• Kondaiah P., Van Obberghen-Schilling E., Ludwig R. L., Dhar R., Sporn M. B., Roberts A. B. cDNA cloning of porcine transforming growth factor-β1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem. 1988; 263(34)18313–18317
   PubMed Web of Science ®Google Scholar
• Kuruvilla A. P., Shah R., Hochwald G. M., Liggitt H. D., Pal-Ladino M. A., Thorbecke G. J. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 1991; 88(7)2918–2921
   PubMed Web of Science ®Google Scholar
• Lastres P., Letamendía A., Zhang H., Rius C., Almendro N., Raab U., López L. A., Langa C., Fabra A., Letarte M., Bernabéu C. Endoglin modulates cellular responses to TGF-β1. J Cell Biol. 1996; 133(5)1109–1121
   PubMed Web of Science ®Google Scholar
• Lee S. J., Nathans D. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J. Biol. Chem. 1988; 263(7)3521–3527
   PubMed Web of Science ®Google Scholar
• Lin H. Y., Moustakas A., Knaus P., Wells R. G., Henis Y. I., Lodish H. F. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor. J Biol Chem. 1995; 270(6)2747–2754
   PubMed Web of Science ®Google Scholar
• Lin H. Y., Wang X. F., Ng-Eaton E., Weinberg R. A., Lodish H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992; 68: 775–785
   PubMed Web of Science ®Google Scholar
• Lopez-Casillas F., Wrana J. L., Massagué J. Beta-glycans presents ligand to the TGF-β signaling receptor. Cell 1993; 73(7)1435–1444
   PubMed Web of Science ®Google Scholar
• MacKay K., Robbins A. R., Bruce M. D., Danielpour D. Identification of disulfide-linked transforming growth factor-β1-specific binding proteins in rat glomeruli. J. Biol. Chem. 1990; 265(16)9351–9356
   PubMed Web of Science ®Google Scholar
• Markowitz S., Wang J., Myeroff L., Parsons R., Sun L.-Z., Lutterbaugh J., Fan R. S., Zborowska E., Kinzler K. W., Vogelstein B., Brattain M., Willson J. K. V. Inac-tivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268(5215)1336–1338
   PubMed Web of Science ®Google Scholar
• Massagué J. The transforming growth factor-β family. Anna. Rev. Cell. Biol. 1990; 6: 597–641
   Web of Science ®Google Scholar
• Massague J., Like B. Cellular receptors for type β transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 1985; 260(5)2636–2645
   PubMed Web of Science ®Google Scholar
• McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCormick M. K., Pericak-Vance M. A., Heutink P., Oostra B. A., Haitjema T., West-Erman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M., Marchuk D. A. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994; 8(4)345–351
   PubMed Web of Science ®Google Scholar
• McAllister K. A., Baldwin M. A., Thukkani A. K., Gallione C. J., Berg J. N., Porteous M. E., Guttmacher A. E., Marchuk D. A. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum. Mol Genet. 1995; 4(10)1983–1984
   PubMed Web of Science ®Google Scholar
• Mittl P. R. E., Priestle J. P., Cox D. A., McMaster G., Cer-Letti N., Grütter M. G. The crystal structure of TGF-β3 and comparison to TGF-β2: Implications for receptor binding. Protein Sci. 1996; 5: 1261–1271
   PubMed Web of Science ®Google Scholar
• Myeroff L. L., Parsons R., Kim S.-J., Hedrick L., Cho K. R., Orth K., Mathis M., Kinzler K. W., Lutterbaugh J., Park K., Bang Y.-J., Lee H. Y., Park J.-G., Lynch H. T., Roberts A. B., Vogelstein B., Markowitz S. D. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 1995; 55(23)5545–5547
   PubMed Web of Science ®Google Scholar
• Peltonen J., Hsiao L. L., Jaakkola S., Sollberg S., Aumail-Ley M., Timpl R., Chu M.-L., Uitto J. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J. Invest. Dermatol. 1991; 97(12)240–248
   PubMed Web of Science ®Google Scholar
• Postlethwaite A. E., Seyer J. M. Identification of a chemotactic epitope in human transforming growth factor-β1 spanning amino acid residues 358–374. J. Cell. Physiol. 1995; 164(13)587–592
   PubMed Web of Science ®Google Scholar
• Qian S. W., Burmester J. K., Merwin J. R., Madri J. A., Sporn M. B., Roberts A. B. Identification of a structural domain that distinguishes the actions of the type 1 and 2 iso-forms of transforming growth factor-β on endothelial cells. Proc. Natl. Acad. Sci. USA 1992; 89(14)6290–6294
   PubMed Web of Science ®Google Scholar
• Qian S. W., Burmester J. K., Sun P. D., Huang A., Ohlsen D. J., Suardet L., Flanders K. C., Davies D., Roberts A. B., Spom M. B. Characterization of mutated transforming growth factor-βs which possess unique biological properties. Biochemistry 1994; 33(40)12298–12304
   PubMed Web of Science ®Google Scholar
• Qian S. W., Burmester J. K., Tsang M. L. S., Weatherbee J. A., Hinck A. P., Ohlsen D. J., Sporn M. B., Roberts A. B. Binding affinity of transforming growth factor-β to the type II receptor is determined by the C-terminal region of the molecule. J Biol Chem. 1996; 271(48)30656–30662
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B. The transforming growth factor-βs. Peptide Growth Factors and Their Receptors, M. B. Sporn, A. B. Roberts. Handbook of Experimental Pharmacology, SpringenBerlin, Heidelberg 1990; 1: 419–472, Chapter 8
   Google Scholar
• Rodriguez C., Chen F., Weinberg R. A., Lodish H. F. Cooperative binding of transforming growth factor (TGF)-β2 to the types I and IITGF-β receptors. J. Biol. Chem. 1995; 270(7)15919–15922
   PubMed Web of Science ®Google Scholar
• Schlunegger M. P., Grutter M. G. An unusual feature revealed by the crystal structure at 2.2Å resolution of human transforming growth factor-β2. Nature 1992; 358(6385)430–434
   PubMed Web of Science ®Google Scholar
• Sonis S. T., Lindquist L., VanVugt A., Stewart A. A., Stam K., Qu G.-Y., Iwata K. K., Haley J. D. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β3. Cancer Res. 1994; 54(5)1135–1138
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B. TGF-β: Problems and prospects. Cell Regul. 1990; 1(12)875–882
   PubMedGoogle Scholar
• Suardet L., Gaide A.-C., Calmes J.-M., Sordat B., Givel J.-C., Eliason J. F., Odartchenko N. Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors βl and β2. Cancer Res. 1992; 52(13)3705–3712
   PubMed Web of Science ®Google Scholar
• Wang J., Sun L.-Z., Myeroff L., Wang X., Gentry L. E., Yang J., Liang J., Zborowska E., Markowitz S., Willson J. K. V., Brattain M. G. Demonstration tha mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error positive colon carcinoma cells. J. Biol. Chem. 1995; 270(37)22044–22049
   PubMed Web of Science ®Google Scholar
• Webb D. J., Atkins T. L., Crookston K. P., Burmester J. K., Qian S W., Gonias S. L. Transforming growtt factor-β isoform 2-specific high affinity binding to native α2 macroglobulin. Chimeras identify a sequence that determines affinity for native but not activated α2-macroglobulin. J. Biol Chem. 1994; 269(48)30402–30406
   PubMed Web of Science ®Google Scholar
• Wrana J. L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X. F., Massague J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992; 71(6)1003–1014
   PubMed Web of Science ®Google Scholar
• Yamashita H., ten Dijke P., Franzen P., Miyazono K., Hel din C. H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol Chem. 1994; 269(31)20171–20178
   Web of Science ®Google Scholar
• Zhou G.-H. K., Sechrist G. L., Periyasamy S., Brattain M. G, Mulder K. M. Transforming growth factor β isoform-specific differences in interactions with type I and II transforming growth factor β receptors. Cancer Res. 1995; 55(10)2056–2062
   PubMed Web of Science ®Google Scholar